Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas

Abstract

These results indicate that microglia, beyond the tumor cells, contribute to the observed response of DIPG to EZH2 inhibition. Results highlight the potential importance of microglia as a new therapeutic avenue in DIPG.